Seekyo is a biotechnology company developing the next generation of targeted therapy for solid cancer: TUMOR ACTIVATED THERAPY We aim at a high selectivity in the treatment for solid tumors, boosting efficacy while reducing adverse effects. We aim at improving patients’ Quality of Life.